DERMATOLOGICALS IN BRAZIL

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Cheaper and More Expensive Products Perform Better Than Those in the Mid-priced Segment

Weakening of Various Taboos Provides Opportunities for the Development of New Categories

Competitive Landscape

Bayer Benefits From Introducing A New Dermatologicals Category

Category Data

Table 1 Sales of Dermatologicals by Category: Value 2013-2018

Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Table 5 Forecast Sales of Dermatologicals by Category: Value 2018-2023

Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Executive Summary

Consumer Health Continues To Be One of the Few Industries To Record Positive Growth

Generics Gaining Ground in the OTC Category

Leading Companies Continue To Invest in Marketing Activities To Drive Sales

Internet Retailing Continues To Slowly Gain Share

Further Solid Growth Anticipated Over the Forecast Period

Market Indicators

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 8 Life Expectancy at Birth 2013-2018

Market Data

Table 9 Sales of Consumer Health by Category: Value 2013-2018

Table 10 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 11 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 12 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 13 Distribution of Consumer Health by Format: % Value 2013-2018

Table 14 Distribution of Consumer Health by Format and Category: % Value 2018

Table 15 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Definitions

Sources

Summary 1 Research Sources

In 2018, mid-priced dermatologicals posted a weaker performance than both cheap and more expensive products. Consumers continued to focus on getting the best value for money, with many purchasing more affordable items in several categories so as to adapt to the still challenging economic climate in Brazil. However, many other more expensive products also performed well. Innovative products or those which offer significant value-added benefits continued to be well-received by consumers, who were...

Euromonitor International's Dermatologicals in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.